ABELIOVICH ASA enters PREVAIL THERAPEUTICS INC. with 2.35M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/19/2019ACC: 0001209191-19-038115
DirectorOfficer10% Owner· President & CEO
Since Jun 2019
2.35M
Baseline shares
100% direct
2.35M
Direct ownership
1 position
1.63M
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned2.35M
Total
2.35M direct2.35M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.35M | Direct |
| Total | 2.35M | 2.35M direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
299.22K
Shares owned
N/A
Exercise price
10.26
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
1.33M
Shares owned
N/A
Exercise price
0.18
Expiration
—
Exercise window
—
Total
Underlying
1.63M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 10.26 | — | — | 299.22K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 0.18 | — | — | 1.33M | N/A |
| Total | 1.63M | 0.00 | ||||